Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/2H51 stock hub

FRA/2H51 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2H51is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

434.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/2H51FRA/2H51

—

Loading chart…

In the news

Latest news · FRA/2H51

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-660

P25 n/aP50 n/aP75 n/a

ROIC-96.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2H51 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	116
Employees Change	30%
Employees Change Percent	46.15
Enterprise value	EUR 435.5M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 434.3M
Price	EUR 1.25
Price currency	EUR
Rev Per Employee	33,383.58x
Sic	2836
Symbol	fra/2H51
Website	https://www.ocugen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.31%
EV Earnings	-7.01x
EV/Sales	114.8x
P/B ratio	86.26x
P/S ratio	112.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -30.6M
Gross Profit Growth Q	120.58%
Net Income	EUR -62.2M
Pretax Margin	-1,605.22%
Profit Per Employee	EUR -535,879
ROA	-68.92
Roa5y	-52.65
ROCE	-184.9
ROE	-660
Roe5y	-248.5
ROIC	-96.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	113.59%
Cagr3y	23.65%
Cagr5y	-30.13%
Revenue Growth	-1.26x
Revenue Growth Q	3.51x
Revenue Growth3 Y	15.06x
Revenue Growth5 Y	153.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.07
Assets	EUR 49.4M
Cash	EUR 27.6M
Current Assets	EUR 32.7M
Current Liabilities	EUR 17.6M
Debt	EUR 28.9M
Debt Equity	EUR 5.74
Equity	EUR 5M
Interest Coverage	-12.74
Liabilities	EUR 44.3M
Long Term Assets	EUR 16.7M
Long Term Liabilities	EUR 26.8M
Net Cash	EUR -1.2M
Net Cash By Market Cap	EUR -0.29
Net Debt Equity	EUR 0.25
Tangible Book Value	EUR 5M
Tangible Book Value Per Share	EUR 0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.86
Net Working Capital	EUR -7.1M
Quick ratio	1.54
Working Capital	EUR 15.5M
Working Capital Turnover	EUR 0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	113.48%
200-day SMA	1.28
3Y total return	89.08%
50-day SMA	1.61
50-day SMA vs 200-day SMA	50over200
5Y total return	-83.34%
All Time High	16.16
All Time High Change	-92.24%
All Time High Date	2021-11-03
All Time Low	0.33
All Time Low Change	285.37%
All Time Low Date	2023-12-13
ATR	0.1
Ch YTD	0.8
High	1.26
High52	2.35
High52 Date	2026-03-16
High52ch	-46.68%
Low	1.23
Low52	0.58
Low52 Date	2025-05-08
Low52ch	115.84%
Ma50ch	-22.26%
Price vs 200-day SMA	-1.65%
RSI	37.8
RSI Monthly	52.31
RSI Weekly	47.44
Sharpe ratio	1.19x
Sortino ratio	2
Total Return	-9.86%
Tr YTD	0.8
Tr1m	-14.93%
Tr1w	-22.4%
Tr3m	7.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -58M
Operating margin	-1,498.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	316,858,026%
Shares Insiders	1.35%
Shares Institutions	22.9%
Shares Qo Q	2.59%
Shares Yo Y	9.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	8,469x
Bv Per Share	0.02
Ch1m	-14.93
Ch1w	-22.4
Ch1y	113.5
Ch3m	7.18
Ch3y	89.08
Ch5y	-83.34
Ch6m	9.33
Change	0.32%
Change From Open	2.12
Close	1.25
Days Gap	-1.76
Depreciation Amortization	1,761,429.1
Dollar Volume	5,266.8
Earnings Date	2026-05-05
EBIT	EUR -58M
EBITDA	EUR -56.2M
EPS	EUR -0.2
F Score	1
Fiscal Year End	December
Founded	2,013
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	1.38
Ma150ch	-9.06%
Ma20	1.47
Ma20ch	-14.64%
Next Earnings Date	2026-08-07
Open	1.23
Position In Range	76.47
Ppne	11,727,314.5
Price Date	2026-05-08
Ptbv Ratio	86.26
Relative Volume	0.5x
Revenue	3,872,495x
Tr6m	9.33%
Volume	4,200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/2H51 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2H51 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/2H51?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.9%

Share of float held by funds and institutions

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.9%

Negative means the company is buying back shares.

Technical

FRA/2H51 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.8

Neutral momentum band

Price vs 200-day MA

-1.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2H51

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2H51 stock rating?

fra/2H51 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2H51 analysis?

The full report lives at /stocks/fra/2H51/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2H51?

The latest report frames fra/2H51 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2H51 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.